UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

þ		QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2007

o		TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission File Number 001-33155

IPG PHOTONICS CORPORATION

Delaware		04-3444218
(State or other jurisdiction of		(I.R.S. Employer
incorporation or organization)		Identification Number)
50 Old Webster Road, Oxford, Massachusetts		01540
(Address of principal executive offices)		(Zip code)

     Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. YES þ       NO o

     Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer or a non-accelerated filer. See definition of “accelerated filer and large accelerated filer” in Rule 12b-2 of the Exchange Act. (Check one):

Large Accelerated Filer o       Accelerated Filer o       Non-Accelerated Filer þ

     Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). YES o       NO þ

     As of August 8, 2007, there were 43,338,632 shares of the registrant’s common stock issued and outstanding.

 

 

TABLE OF CONTENTS

		PAGE
Part I. Financial Information
Item 1. Unaudited Interim Financial Statements
Consolidated Balance Sheets: June 30, 2007 and December 31, 2006			3
Consolidated Statements of Operations: Three and Six Months Ended June 30, 2007 and 2006			4
Consolidated Statements of Cash Flows: Six Months Ended June 30, 2007 and 2006			5
Notes to Consolidated Financial Statements			6
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations			11
Item 3. Quantitative and Qualitative Disclosures About Market Risk			16
Item 4. Controls and Procedures			16
Part II. Other Information
Item 1. Legal Proceedings			16
Item 1A. Risk Factors			16
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds			17
Item 3. Defaults Upon Senior Securities			17
Item 4. Submission of Matters to a Vote of Security Holders			17
Item 5. Other Information			17
Item 6. Exhibits			18
Signatures			19
EX-10.1 Loan Agreement dated as of July 26, 2007
EX-10.2 Revolving Credit Note dated July 26, 2007
EX-31.1 Section 302 Certification of CEO
EX-31.2 Section 302 Certification of CFO
EX-32 Section 906 Certification of CEO & CFO

PART I—FINANCIAL INFORMATION

Item 1. Unaudited Interim Financial Statements

IPG PHOTONICS CORPORATION

		June 30,				December 31,
		2007				2006
		(In thousands, except share and per share data)
ASSETS
CURRENT ASSETS:
Cash and cash equivalents		$	46,709			$	75,667
Accounts receivable, net			26,726				22,353
Inventories, net			52,691				42,162
Income taxes receivable			5,881				80
Prepaid expenses and other current assets			7,914				6,586
Deferred income taxes			8,717				9,591
Total current assets			148,638				156,439
DEFERRED INCOME TAXES			3,506				3,801
PROPERTY, PLANT AND EQUIPMENT, Net			81,483				67,153
OTHER ASSETS			6,498				5,099
TOTAL		$	240,125			$	232,492
LIABILITIES AND STOCKHOLDERS’ EQUITY
CURRENT LIABILITIES:
Revolving line-of-credit facilities		$	10,732			$	2,603
Current portion of long-term debt			—				8,299
Accounts payable			10,788				7,640
Accrued expenses and other liabilities			14,380				13,940
Income taxes payable			1,930				8,289
Total current liabilities			37,830				40,771
DEFERRED INCOME TAXES			4,955				232
LONG-TERM DEBT			20,000				30,068
COMMITMENTS AND CONTINGENCIES
MINORITY INTERESTS			3,415				2,827
STOCKHOLDERS’ EQUITY:
Common stock, $0.0001 par value, 175,000,000 shares authorized, 43,197,920 shares issued and outstanding at June 30, 2007; 42,901,612 shares issued and outstanding at December 31, 2006			4				4
Additional paid-in capital			272,326				271,122
Notes receivable from stockholders			—				(23	)
Accumulated deficit			(107,391	)			(120,392	)
Accumulated other comprehensive income			8,986				7,883
Total stockholders’ equity			173,925				158,594
TOTAL		$	240,125			$	232,492

See notes to consolidated financial statements.

IPG PHOTONICS CORPORATION

		Three Months Ended								Six Months Ended
		June 30,								June 30,
		2007				2006				2007				2006
		(In thousand, except per share data)
NET SALES		$	43,952			$	32,184			$	85,705			$	64,927
COST OF SALES			23,633				18,841				46,055				39,119
GROSS PROFIT			20,319				13,343				39,650				25,808
OPERATING EXPENSES:
Sales and marketing			2,836				1,263				4,745				2,343
Research and development			2,388				1,387				4,517				2,622
General and administrative			4,989				3,154				9,230				5,813
Total operating expenses			10,213				5,804				18,492				10,778
OPERATING INCOME			10,106				7,539				21,158				15,030
OTHER INCOME (EXPENSE), NET:
Interest income (expense), net			117				(354	)			513				(709	)
Fair value adjustment to Series B Warrants			—				(357	)			—				(2,219	)
Other (expense) income, net			(8	)			4				36				12
Total other income (expense)			109				(707	)			549				(2,916	)
INCOME BEFORE PROVISION FOR INCOME TAXES AND MINORITY INTERESTS IN CONSOLIDATED SUBSIDIARIES			10,215				6,832				21,707				12,114
PROVISION FOR INCOME TAXES			(3,611	)			(1,939	)			(8,118	)			(3,866	)
MINORITY INTERESTS IN CONSOLIDATED SUBSIDIARIES			(216	)			(110	)			(588	)			(398	)
NET INCOME		$	6,388			$	4,783			$	13,001			$	7,850
NET INCOME PER SHARE:
Basic		$	0.15			$	0.13			$	0.30			$	0.22
Diluted		$	0.14			$	0.12			$	0.29			$	0.19
WEIGHTED-AVERAGE SHARES OUTSTANDING:
Basic			42,974				27,074				42,942				26,923
Diluted			45,631				31,156				45,616				30,908

See notes to consolidated financial statements.

IPG PHOTONICS CORPORATION

		Six Months Ended
		June 30,
		2007				2006
		(In thousands)
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income		$	13,001			$	7,850
Adjustments to reconcile net income to net cash (used in) provided by operating activities:
Depreciation and amortization			5,410				3,754
Deferred income taxes			380				3,063
Stock-based compensation			509				126
Changes related to realized and unrealized (gains)losses on foreign currency transactions			(350	)			321
Other			(34	)			328
Fair value adjustment to Series B Warrants			—				2,219
Provisions for inventory, warranty & bad debt			2,072				298
Minority interests in consolidated subsidiaries			588				398
Changes in assets and liabilities that provided (used) cash:
Accounts receivable			(4,651	)			(2,474	)
Inventories			(11,746	)			(6,389	)
Prepaid expenses and other current assets			(2,620	)			(1,251	)
Accounts payable			2,840				678
Accrued expenses and other liabilities			(273	)			976
Income and other taxes payable			(7,117	)			411
Net cash (used in) provided by operating activities			(1,991	)			10,308
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of property, plant and equipment			(17,859	)			(9,054	)
Proceeds from sale of property, plant and equipment			78				20
Employee and stockholder loans repaid			17				1,071
Net cash used in investing activities			(17,764	)			(7,963	)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from line-of-credit facilities			20,298				8,517
Payments on line-of-credit facilities			(12,118	)			(6,325	)
Principal payments on long-term borrowings			(18,177	)			(2,688	)
Exercise of employee stock options and related tax benefit from exercise			851				905
Net cash (used in) provided by financing activities			(9,146	)			409
EFFECT OF CHANGES IN EXCHANGE RATES ON CASH AND CASH EQUIVALENTS			(57	)			167
NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS			(28,958	)			2,921
CASH AND CASH EQUIVALENTS — Beginning of period			75,667				8,361
CASH AND CASH EQUIVALENTS — End of period		$	46,709			$	11,282
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION:
Cash paid for interest		$	350			$	716
Income taxes paid		$	13,940			$	781

See notes to consolidated financial statements.

IPG PHOTONICS CORPORATION

1. BASIS OF PRESENTATION

     The accompanying interim unaudited consolidated financial statements have been prepared by IPG Photonics Corporation, or “IPG”, “we”, “our”, or “the Company”. Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles in the United States of America have been condensed or omitted pursuant to the rules and regulations of the Securities and Exchange Commission. The consolidated financial statements include our accounts and those of our subsidiaries. All intercompany balances have been eliminated in consolidation. These consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto in our annual report on Form 10-K for the year ended December 31, 2006.

     In the opinion of our management, the unaudited financial information for the interim periods presented reflects all adjustments necessary for a fair presentation of our financial position, results of operations and cash flows. The results reported in these consolidated financial statements are not necessarily indicative of results that may be expected for the entire year.

2. RECENT ACCOUNTING PRONOUNCEMENTS

     In July 2006, the FASB issued Financial Accounting Standards Interpretation No. 48, Accounting for Uncertainty in Income Taxes (“FIN 48”). FIN 48 prescribes a recognition threshold and measurement process for recording in the financial statements uncertain tax positions taken or expected to be taken in a tax return. FIN 48 also provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosures and transitions. FIN 48 became effective for us beginning January 1, 2007. We identified and reviewed potential uncertainties related to taxes upon the adoption of FIN 48. We determined that the exposure to those uncertainties did not have a material impact on our results of operations or financial condition.

     In September 2006, the FASB issued SFAS No. 157, Fair Value Measurements (“SFAS No. 157”), which addresses how companies should measure fair value when they are required to use a fair value measure for recognition or disclosure purposes under generally accepted accounting principles. The provisions of SFAS No. 157 are effective for us beginning after January 1, 2008. We have not yet adopted this pronouncement and we are currently evaluating the expected impact that the adoption of SFAS No. 157 will have on our consolidated financial position and results of operations.

     In February 2007, the FASB issued SFAS No. 159, The Fair Value Option for Financial Assets and Financial Liabilities (“SFAS No. 159”), which provides companies with an option to report selected financial assets and liabilities at fair value. SFAS No. 159 also establishes presentation and disclosure requirements relating to the use of fair values within the financial statements. The provisions of SFAS No. 159 are effective for us beginning after January 1, 2008. We have not yet adopted this pronouncement and are currently evaluating the expected impact that the adoption of SFAS No. 159 will have on our consolidated financial position and results of operations.

3. INVENTORIES

     Inventories consist of the following (in thousands):

		June 30,				December 31,
		2007				2006
Components and raw materials		$	21,964			$	19,244
Work-in-process			18,827				12,886
Finished goods			11,900				10,032
Total		$	52,691			$	42,162

4. FINANCING ARRANGEMENTS

     The Company’s borrowings under existing financing arrangements consist of the following (in thousands):

		June 30,				December 31,
		2007				2006
Revolving Line-of-Credit Facilities:
Euro Overdraft Facilities		$	3,159			$	84
U.S. Line of Credit			4,300				—
Japanese Line of Credit			—				2,519
Chinese Line of Credit			3,273				—
Total		$	10,732			$	2,603
Term Debt:
U.S. Construction Loan		$	—			$	5,589
Subordinated Notes			20,000				20,000
Euro Construction Loan			—				2,886
Euro Variable Rate Loan			—				6,267
Other term debt			—				3,625
Total term debt			20,000				38,367
Less current portion			—				(8,299	)
Long-term debt		$	20,000			$	30,068

Revolving Line-of-Credit Facilities:

     Euro Overdraft Facilities — The Company maintains a syndicated overdraft facility with available principal of Euro 4,895,500 (approximately $6,596,000 at June 30, 2007). Of the total amount, Euro 1,873,000 (approximately $2,524,000 at June 30, 2007) is available at least through June 2010 and Euro 3,022,500 (approximately $4,072,000 at June 30, 2007) is available through September 2007. This facility bears interest at market rates that vary depending upon the bank within the syndicate that advances the principal outstanding (from 6.8% to 9.0% at June 30, 2007). This facility is collateralized by a common pool of the assets of the Company’s German subsidiary, IPG Laser GmbH. At June 30, 2007, the remaining availability under the Euro Overdraft Facility totaled $3,578,000.

     The Company also maintains Euro credit lines in Italy with available principal of Euro 650,000 (approximately $876,000 as of June 30, 2007) which bear interest at rates ranging from 4.2% to 5.3%. At June 30, 2007, the remaining availability under the Euro credit lines was $735,000.

     U.S. Line of Credit — Until July 2007 the Company maintained a credit line with available principal of 80% of eligible receivables, up to $7,000,000, on a revolving basis. This facility bears interest at a variable rate of LIBOR plus 3% (8.3% at June 30, 2007). The facility was collateralized by all the assets held by the U.S. parent company. At June 30, 2007, the remaining availability under the U.S. Line of Credit totaled $1,370,000. The Company repaid all amounts outstanding under this line and terminated this facility in July 2007.

     Japanese Line of Credit — The Company maintains two credit lines with available principal of 100% of eligible receivables, up to JPY 600,000,000 (approximately $4,865,000 at June 30, 2007), on a revolving basis. These facilities bear interest at rates ranging from 2.13% to 2.25% at June 30, 2007. The facility is renewable annually and collateralized by accounts receivable and inventory in Japan. At June 30, 2007, the total and remaining availability under the Japanese Line of Credit totaled $1,674,000.

     Chinese Line of Credit — The Company maintains a credit line with available principal up to RMB 24,951,000 (approximately $3,273,000 at June 30, 2007), on a revolving basis. This facility bears interest at a floating rate of 110% of Renminbi base rate (6.7% at June 30, 2007).

     In July 2007, the Company entered into a new $20.0 million unsecured revolving line of credit expiring in July 2010. The new line of credit replaced the U.S. receivables-based, secured line of credit of up to $7.0 million. The new line of credit bears interest at a variable rate of LIBOR plus 0.8% to 1.2% depending, on the Company’s financial performance.

     Term Debt:

     In the first quarter of 2007, we used $18.2 million of cash to repay substantially all of our bank term debt outstanding as of December 31, 2006 except for the $20.0 million subordinated, unsecured, variable-rate notes, which mature in 2009. The Company issued subordinated notes to the holders of its Series B convertible redeemable preferred stock upon conversion of their shares in December 2006. The subordinated notes bear interest at the greater of the short-term applicable Federal rate (4.97% at December 31, 2006), as published by the Internal Revenue Service, or 4% in the first year, 7% in the second year and 10% in the third year. The notes mature in December 2009 and may be prepaid without penalty.

5. NET INCOME PER SHARE

     For periods during which the Company had two classes of equity securities issued and outstanding, it followed EITF Issue No. 03-6, Participating Securities and the Two-Class Method under FASB Statement No. 128 (“EITF 03-6”), which established standards regarding the computation of net income per share by companies that have issued securities other than common stock that contractually entitle the holder to participate in dividends and earnings of the company. EITF 03-6 requires earnings available to common stockholders for the period, after deduction of preferred stock accretion and deemed dividends related to beneficial conversion features, to be allocated between the common and convertible securities based on their respective rights to receive dividends. Basic net income per share is then calculated by dividing income applicable to common stockholders by the weighted- average number of shares outstanding. EITF 03-6 does not require the presentation of basic and diluted net income per share for securities other than common stock; therefore, the following per share amounts only pertain to the Company’s common stock.

     The Company calculates diluted net income per share under the if-converted method unless the conversion of the convertible preferred stock is dilutive to basic net income per share. To the extent convertible preferred stock is dilutive, the Company calculates diluted net income per share under the two-class method to include the effect of potential common shares.

     The share count used to compute basic and diluted net income per share is calculated as follows (in thousands):

		Three Months								Six Months
		Ended June 30,								Ended June 30,
		2007				2006				2007				2006
Weighted-average common shares outstanding used to compute basic net income per share:
two classes of equity securities were outstanding for the three and six months ended June 30, 2006			—				27,074				—				26,923
Weighted-average common shares outstanding used to compute basic net income per share after conversion of convertible redeemable preferred stock; one class of equity securities was outstanding for the three and six months ended June 30, 2007			42,974				—				42,942				—
Weighted-average common shares outstanding			42,974				27,074				42,942				26,923
Add dilutive common equivalents:
Stock options			2,657				2,293				2,674				2,196
Series A preferred stock			—				—				—				—
Series B preferred stock			—				—				—				—
Series D preferred stock			—				—				—				—
Convertible supplier note payable			—				1,789				—				1,789
Shares used to compute diluted net income per share			45,631				31,156				45,616				30,908

     The following is a summary of the securities outstanding during the respective periods that have been excluded from the calculations because the effect on net income per share would have been anti-dilutive (in thousands):

		Three Months								Six Months
		Ended June 30,								Ended June 30,
		2007				2006				2007				2006
Actual securities excluded because they would have been anti-dilutive
Stock options			110				—				110				—
Series A preferred stock			—				328				—				358
Series B preferred stock			—				2,944				—				2,918
Series D preferred stock			—				1,789				—				1,789

     The Series B Warrants were only exercisable upon the completion of an initial public offering of the Company’s common stock or the sale, liquidation, or merger of the Company and, as such, any shares that would have been issued upon the exercise of the Series B Warrants were excluded from the computations of net income per share for all applicable periods presented.

     The following table sets forth the computation of basic and diluted net income per share (in thousands, except per share data):

		Three Months								Six Months
		Ended June 30,								Ended June 30,
		2007				2006				2007				2006
Calculation of basic net income per share:
Net income for period during which two classes of equity securites were outstanding		$	—			$	4,783			$	—			$	7,850
Accretion of series B preferred stock			—				(518	)			—				(1,036	)
Net income, net of assumed stock dividends		$	—			$	4,265			$	—			$	6,814
Percent of net income allocable to common stockholders (1)			100	%			85	%			100	%			85	%
Net income allocable to common stockholders			—				3,637				—				5,811
Weighted-average common shares outstanding			—				27,074				—				26,923
Basic net income per share for period during which two classes of equity securites were outstanding		$	—			$	0.13			$	—			$	0.22
Net income for period during which a single class of equity securites was outstanding		$	6,388			$	—			$	13,001			$	—
Weighted-average common shares outstanding			42,974				—				42,942				—
Basic net income per share for period during which a single class of equity securites was outstanding		$	0.15			$	—			$	0.30			$	—
Basic net income per share		$	0.15			$	0.13			$	0.30			$	0.22
Calculation of diluted net income per share:
Net income allocable to common stockholders		$	6,388			$	3,637			$	13,001			$	5,811
Interest expense on convertible supplier note payable			—				64				—				127
Net income allocable to dilutive convertible preferred			—				—				—				—
Net income			6,388				3,701				13,001				5,938
Weighted-average diluted shares outstanding			45,631				31,156				45,616				30,908
Diluted net income per share		$	0.14			$	0.12			$	0.29			$	0.19

		Three Months								Six Months
		Ended June 30,								Ended June 30,
		2007				2006				2007				2006
Weighted-average common shares outstanding			42,974				27,074				42,942				26,923
Weighted-average anti-dilutive convertible preferred stock outstanding			—				5,061				—				5,065
Weighted-average common shares and preferred shares outstanding			42,974				32,135				42,942				31,988
Percent of net income allocable to common stockholders			100	%			85	%			100	%			85	%
Percent of net income allocable to dilutive convertible preferred stockholders			0	%			0	%			0	%			0	%

6. COMPREHENSIVE INCOME

     Total comprehensive income and its components were as follows (in thousands):

		Three Months Ended								Six Months Ended
		June 30,								June 30,
		2007				2006				2007				2006
Net income		$	6,388			$	4,783			$	13,001			$	7,850
Other comprehensive income:
Foreign currency translation adjustment			528				1,271				1,103				1,847
Comprehensive income		$	6,916			$	6,054			$	14,104			$	9,697

Total accumulated other comprehensive income at each balance sheet date is comprised solely of the cumulative translation adjustment related to our foreign operations.

7. STOCK OPTIONS

A summary of option activity is presented below:

										Weighted-Average
										Remaining				Aggregate Intrinsic
		Number of				Weighted-Average				Contractual Life				Value
		Options				Exercise Price				(in years)				(in thousands)
Outstanding — January 1, 2007			4,392,161			$	2.70				7.31			$	93,552
Granted			228,002				19.10
Exercised			(296,308	)			1.92
Forfeited			(21,702	)			14.17
Outstanding — June 30, 2007			4,302,153			$	3.56				7.04			$	70,536
Exercisable — June 30, 2007			2,470,612			$	1.90				5.85			$	44,598
Exercisable — January 1, 2007			2,239,561			$	1.57				5.87			$	50,230

     The weighted-average grant-date fair value of the options granted to employees in the six months ended June 30, 2007 was $13.37. The intrinsic value of the options exercised during the six months ended June 30, 2007 was $5,649,225.

     The total compensation cost related to non-vested awards not yet recorded at June 30, 2007 was $5,430,000, net of estimated forfeitures of 5%, which is expected to be recognized over 3.6 years on a weighted-average basis.

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

     You should read the following discussion in conjunction with our consolidated financial statements and related notes included elsewhere in this Quarterly Report on Form 10-Q. This discussion contains forward looking statements that are based on management’s current expectations, estimates and projections about our business and operations. Our actual results may differ materially from those currently anticipated and expressed in such forward-looking statements. See “Cautionary Statement Regarding Forward-Looking Statements.”

Overview

     We develop and manufacture a broad line of high-performance fiber lasers, fiber amplifiers and diode lasers for diverse applications in numerous markets. Our diverse lines of low, mid and high-power lasers and amplifiers are used in materials processing, communications, medical and advanced applications. We sell our products globally to original equipment manufacturers, or OEMs, system integrators and end users. We market our products internationally primarily through our direct sales force and also through agreements with independent sales representatives and distributors.

     We are vertically integrated such that we design and manufacture all key components used in our finished products, from semiconductor diodes to optical fiber preforms, finished fiber lasers and amplifiers. Since our formation in 1990, we have been focused on developing and manufacturing high-power fiber lasers and amplifiers. We established manufacturing and research operations in Germany in 1994 and in the United States in 1998. In December 2006, we completed our initial public offering of 10,350,000 shares of common stock at $16.50 per share (the “IPO”), comprised of 6,241,379 primary shares and 4,108,621 shares offered by selling stockholders. In connection with the IPO, all of the outstanding shares of our preferred stock were converted into an aggregate of 9,295,558 shares of the Company’s common stock.

     In April 2007, we opened a new sales and service center in Beijing, China by acquiring certain assets and hiring certain staff from a former distributor. Also, we purchased a new 34,000 square foot facility in Beijing for the new operations in China.

Factors and Trends That Affect Our Operations and Financial Results

     In reading our financial statements, you should be aware of the following factors and trends that our management believes are important in understanding our financial performance.

     Net sales. Our net sales have historically fluctuated from quarter to quarter. The increase and decrease in sales from a prior quarter can be affected by the timing of orders received from customers, the shipment, installation and acceptance of products at our customers’ facilities, the mix of OEM orders and one-time orders for products with large purchase prices, and seasonal factors such as the purchasing patterns and levels of activity throughout the year in the regions where we operate. Historically, our net sales have been higher in the second half of the year than in the first half of the year. Furthermore, net sales can be affected by the time taken to qualify our products for use in new applications in the end markets that we serve. The adoption of our products by a new customer or qualification in a new application can lead to an increase in net sales for a period, which may then slow until we further penetrate new markets or customers.

     Gross margin. Our total gross margin in any period can be affected by total net sales in any period, product mix, that is, the percentage of our revenue in that period that is attributable to higher- or lower-power products, and by other factors, some of which are not under our control. Due to the fact that we have high fixed costs, our costs are difficult to adjust in response to changes in demand. Therefore, our manufacturing costs as a percentage of net sales are volatile and can increase or decrease depending on total net sales reported in a period. Our product mix affects our margins because the selling price per watt is higher for low and mid-power devices than for high-power devices. The overall cost of high-power lasers may be partially offset by improved absorption of fixed overhead costs associated with sales of larger volumes of higher-power products. We regularly review our inventory for items that have been rendered obsolete or determined to be excess, and any write-off of such obsolete or excess inventory affects our gross margins.

     Sales and marketing expense. We expect to continue to expand our worldwide direct sales organization, build and expand applications centers, hire additional personnel involved in marketing in our existing and new geographic locations, increase the number of units used for demonstration purposes and otherwise increase expenditures on sales and marketing activities in order to support the growth in our net sales. As such, we expect that our sales and marketing expenses will increase in the aggregate.

     Research and development expense. We plan to continue to invest in research and development to improve our existing components and products and develop new components and products. We plan to increase the personnel involved in research and development and expect to increase other research and development expenses. As such, we expect our research and development expenses will increase in the aggregate.

     General and administrative expense. We expect our general and administrative expenses to continue to increase as we expand headcount to support the growth of the Company, public company reporting obligations and regulatory compliance, incur higher insurance expenses related to directors’ and officers’ insurance and continue to invest in our financial reporting systems. Further, legal expenses are expected to increase in response to pending litigation and may increase in response to any future litigation or intellectual property matters, the timing and amount of which may vary substantially from quarter to quarter.

     Major customers. We have historically depended on a few customers for a large percentage of our annual net sales. The composition of this group can change from year to year. Net sales derived from our five largest customers as a percentage of our net sales were 23% in the six months ended June 30, 2007, and 29%, 37% and 37% for the years ended December 31, 2006, 2005 and 2004, respectively. Sales to our largest

customer accounted for less than 10% of our net sales in the first half of 2007. We seek to add new customers and to expand our relationships with existing customers. We anticipate that the composition of our net sales to our significant customers will continue to change. If any of our significant customers were to substantially reduce their purchases from us, our results would be adversely affected.

Results of Operations for the three months ended June 30, 2007 compared to the three months ended June 30, 2006

     Net sales. Net sales increased by $11.8 million, or 36.6%, to $44.0 million for the three months ended June 30, 2007 from $32.2 million for the three months ended June 30, 2006. This increase was attributable to higher sales of fiber lasers in materials processing applications, where net sales increased by $10.8 million, or 46.6%, in medical applications, where net sales increased by $1.7 million, or 78.3%, and in advanced applications, where net sales increased by $0.4 million, or 10.9%. These increases were partially offset by a decrease in sales in communications of $1.1 million, or 36.4%. The growth in materials processing sales resulted primarily from increased market penetration for high-power fiber lasers as well as an increase in sales of pulsed fiber lasers. The growth in medical applications resulted primarily from the increased sales of low-power lasers to our major OEM customer in the United States. In the second quarter of 2007, sales of high-power lasers increased by $4.1 million, or 54.6%, to $11.6 million, sales of low-power lasers increased by $2.7 million, or 47.2%, to $8.3 million, and sales of pulsed lasers increased by $2.5 million, or 23.7%, to $13.2 million, as compared to the same period last year. The decrease in communications sales was due to lower sales of fiber amplifiers to our largest U.S. customer due to increased competition as well as completion of a project with a customer in Asia.

     Cost of sales and gross margin. Cost of sales increased by $4.8 million, or 25.5%, to $23.6 million for the three months ended June 30, 2007 from $18.8 million for the three months ended June 30, 2006, as a result of increased sales volume. Our gross margin increased to 46.2% for the three months ended June 30, 2007 from 41.5% for the three months ended June 30, 2006. The increase in gross margin compared to the same period last year is primarily the result of more favorable absorption of our fixed manufacturing costs due to higher production volumes, ongoing initiatives to improve manufacturing efficiencies and continuing decreases in the cost of our internally manufactured optical components, including improvement in high-power fiber modules and packaged diodes. These gains were partially offset by a provision for slow-moving and obsolete inventory of $1.1 million as compared to $0.2 million in the second quarter of 2006.

     Sales and marketing expense. Sales and marketing expense increased by $1.5 million, or over 100%, to $2.8 million for the three months ended June 30, 2007 from $1.3 million for the three months ended June 30, 2006, primarily as a result of an increase of $0.8 million in selling expenses related to an increase in the number of units used for demonstration purposes. To a lesser extent, the increase was due to higher personnel costs related to the expansion of our worldwide direct sales organization, including our new sales and service center in China.

     Research and development expense. Research and development expense increased by $1.0 million, or 71.4%, to $2.4 million for the three months ended June 30, 2007 from $1.4 million for the three months ended June 30, 2006. This increase is primarily due to an increase of $0.7 million in personnel costs to support increased research and development activity. Research and development activity continues to focus on enhancing the performance of our internally manufactured components, refining production processes to improve manufacturing yields and the development of new products operating at different wavelengths and at higher output powers.

     General and administrative expense. General and administrative expense increased by $1.8 million, or 56.3%, to $5.0 million for the three months ended June 30, 2007 from $3.2 million for the three months ended June 30, 2006, primarily due to an increase of $0.8 million in personnel expenses as we expanded the general and administrative function to support the growth of the business and comply with the reporting and regulatory requirements of a public company, higher stock-compensation costs and increased expenses related to our new office in China. Legal, consulting and accounting costs increased by $0.8 million primarily related to audit fees, Sarbanes-Oxley Act compliance costs, tax compliance initiatives, on-going systems implementation and patent litigation defense fees. Additionally, insurance costs increased $0.2 million.

     Interest (income) expense, net. Interest (income) expense, net decreased by $0.5 million to net interest income of $0.1 million for the three months ended June 30, 2007 from net interest expense of $0.4 million for the three months ended June 30, 2006. The change in interest (income) expense, net resulted from lower interest expense incurred after the repayment of all of our term debt in the first quarter of 2007 and higher interest income earned on the net proceeds from our IPO, partially offset by higher utilization of our line-of-credit facilities.

     Fair value adjustment to series B warrants. There was no expense related to the fair value adjustment of the series B warrants for the three months ended June 30, 2007 as compared to $0.4 million for the three months ended June 30, 2006 because we repurchased the series B warrants in December 2006. As a result, there will be no further charges to record the change in the fair value of the series B warrants.

     Provision for income taxes. Provision for income taxes increased by $1.7 million to $3.6 million for the three months ended June 30, 2007 from $1.9 million for the three months ended June 30, 2006, representing an effective tax rate of 35.3% in the three months ended June 30, 2007 as compared to 28.4% in the same period last year. The increase in the provision for income taxes resulted from higher pre-tax income and a higher effective tax rate. Excluding the fair value adjustment to series B warrants, the effective tax rate was 27.0% for the three months ended June 30, 2006. The increase in the effective tax rate in 2007 is primarily due to an effective tax rate applied to U.S.-generated income of approximately 34% in the second quarter of 2007 as compared to an effective rate of zero percent in the second quarter of 2006. The valuation allowance for U.S. federal net operating losses was released in the fourth quarter of 2006 and, accordingly, there is no benefit from the release of the valuation allowance in the second quarter of 2007 for U.S. federal net operating losses used.

     Net income. Net income increased by $1.6 million to $6.4 million for the three months ended June 30, 2007 from $4.8 million for the three months ended June 30, 2006. Net income as a percentage of our net sales decreased by 0.4 percentage points to 14.5% for the three months ended June 30, 2007 from 14.9% for the same period in 2006.

Results of Operations for the six months ended June 30, 2007 compared to the six months ended June 30, 2006

     Net sales. Net sales increased by $20.8 million, or 32.0%, to $85.7 million for the six months ended June 30, 2007 from $64.9 million for the six months ended June 30, 2006. This increase was attributable to higher sales of fiber lasers in materials processing applications, where net sales increased by $21.8 million or 48.7%, advanced applications, where net sales increased by $2.0 million, or 28.9% and medical applications, where net sales increase by $1.0 million, or 19.8%. These increases were partially offset by a decrease in sales in communications of $4.0 million, or 48.5%. The growth in materials processing sales resulted primarily from increased market penetration for high-power fiber lasers as well as an increase in sales of pulsed and medium-power fiber lasers. In the first six months of 2007, sales of high-power lasers increased by $9.8 million, or 64.8%, to $24.9 million, sales of pulsed lasers increased by $6.4 million, or 33.9%, to $25.1 million and sales of medium-power lasers increased by $2.7 million, or 38.3%, to $9.7 million, as compared to the same period last year. The decrease in communications sales was due to lower sales of fiber amplifiers to our largest U.S. telecom customer due to increased competition as well as completion of a project with a customer in Asia.

     Cost of sales and gross margin. Cost of sales increased by $7.0 million, or 17.9%, to $46.1 million for the six months ended June 30, 2007 from $39.1 million for the six months ended June 30, 2006, as a result of increased sales volume. Our gross margin increased to 46.3% for the six months ended June 30, 2007 from 39.7% for the six months ended June 30, 2006. The increase in gross margin compared to the same period last year is primarily the result of more favorable absorption of our fixed manufacturing costs due to higher production volumes, ongoing initiatives to improve manufacturing efficiencies and continuing decreases in the cost of our internally manufactured optical components, including improvement in high-power fiber modules and packaged diodes. These gains were partially offset by a provision for slow-moving and obsolete inventory of $1.1 million as compared to $0.3 million in the six months ended June 30, 2006.

     Sales and marketing expense. Sales and marketing expense increased by $2.4 million, or over 100%, to $4.7 million for the six months ended June 30, 2007 from $2.3 million for the six months ended June 30, 2006, primarily as a result of an increase of $1.1 million in selling expenses related to an increase in the number of units used for demonstration purposes. To a lesser extent the increase was due to higher personnel costs related to the expansion of our worldwide direct sales organization, including our new sales and service center in China.

     Research and development expense. Research and development expense increased by $1.9 million, or 73.1%, to $4.5 million for the six months ended June 30, 2007 from $2.6 million for the six months ended June 30, 2006. This increase is primarily due to an increase of $1.7 million in personnel costs to support increased research and development activity. Research and development activity continues to focus on enhancing the performance of our internally manufactured components, refining production processes to improve manufacturing yields and the development of new products operating at different wavelengths and at higher output powers.

     General and administrative expense. General and administrative expense increased by $3.4 million, or 58.6%, to $9.2 million for the six months ended June 30, 2007 from $5.8 million for the six months ended June 30, 2006, primarily due to an increase of $1.5 million in personnel expenses as we expanded the general and administrative function to support the growth of the business and comply with the reporting and regulatory requirements of a public company, higher stock-compensation costs and increased expenses related to our new office in China. Legal, consulting and accounting costs increased by $1.7 million due primarily to audit fees, Sarbanes-Oxley Act compliance costs, tax compliance initiatives and patent litigation defense fees. Bad debt expense and insurance costs also increased by $0.4 million each. The increase was partially offset by realized and unrealized gains related to foreign currency of $0.5 million in the first six months of 2007 compared to a $0.1 million loss in the same period last year.

     Interest (income) expense, net. Interest (income) expense, net decreased by $1.2 million to net interest income of $0.5 million for the six months ended June 30, 2007 from net interest expense of $0.7 million for the six months ended June 30, 2006. The change in interest (income) expense, net resulted from lower interest expense incurred after the repayment of all of our term debt in the first quarter of 2007 and higher interest income earned on the net proceeds from our IPO.

     Fair value adjustment to series B warrants. There was no expense related to the fair value adjustment of the series B warrants for the six months ended June 30, 2007 as compared to $2.2 million for the six months ended June 30, 2006 because we repurchased the series B warrants in December 2006. As a result, there will be no further charges to record the change in the fair value of the series B warrants.

     Provision for income taxes. Provision for income taxes increased by $4.2 million to $8.1 million for the six months ended June 30, 2007 from $3.9 million for the six months ended June 30, 2006, representing an effective tax rate of 37.4% in the six months ended June 30, 2007 as compared to 31.9% in the same period last year. The increase in the provision for income taxes resulted from higher pre-tax income and a higher effective tax rate. Excluding the fair value adjustment to series B warrants, the effective tax rate was 27.0% for the six months ended June 30, 2006. The increase in the effective tax rate in 2007 is primarily due to an effective tax rate applied to U.S.-generated income of approximately 34% in the first six months of 2007 as compared to an effective rate of zero percent in the first six months of 2006. The valuation allowance for U.S. federal net operating losses was released in the fourth quarter of 2006 and, accordingly, there is no benefit from the release of the valuation allowance in the first six months of 2007 for U.S. federal net operating losses used.

     Net income. Net income increased by $5.2 million to $13.0 million for the six months ended June 30, 2007 from $7.8 million for the six months ended June 30, 2006. Net income as a percentage of our net sales increased by 3.2 percentage points to 15.2% for the six months ended June 30, 2007 from 12.0% for the same period in 2006.

Liquidity and Capital Resources

     Our principal sources of liquidity as of June 30, 2007 consisted of cash and cash equivalents of $46.7 million and unused credit lines and overdraft facilities of $7.4 million and working capital (excluding cash) of $64.1 million. This compares to cash and cash equivalents of $75.7 million, unused credit lines and overdraft facilities of $13.8 million and working capital (excluding cash) of $40.0 million as of December 31, 2006. The decrease in cash and cash equivalents of $29.0 million from December 31, 2006 relates primarily to the repayment of long-term debt of $18.2 million and capital expenditures of $17.8 million, partially offset by net proceeds from our credit lines of $8.2 million.

     In the first quarter of 2007, we used $18.2 million of the proceeds from our IPO to repay substantially all of our bank term debt except for the $20.0 million subordinated, unsecured, variable-rate notes described in Note 4 to our consolidated financial statements, which mature in 2009. We expect that the remaining proceeds and our existing lines-of-credit will be sufficient to meet our liquidity and capital needs for the foreseeable future. Our future long-term capital requirements will depend on many factors including our rate of net sales growth, the timing and extent of spending to support development efforts, the expansion of our sales and marketing activities, the timing and introductions of new products, the need to ensure access to adequate manufacturing capacity and the continuing market acceptance of our products. We have made no arrangements to obtain additional financing, and there is no assurance that such additional financing, if required or desired, will be available in amounts or on terms acceptable to us, if at all.

Although we repaid substantially all our fixed-term debt in the first quarter of 2007, we intend to maintain and use availability under our lines of credit to finance our short-term working capital requirements that may arise from time to time.

     The following table details our line-of-credit facilities as of June 30, 2007:

Description		Available Principal		Interest Rate		Maturity		Security
Euro Overdraft		Euro 4.9 million		6.8% – 9.0% depending		September		Common pool of
Facilities (Germany) (1)		($6.6 million)		upon principal outstanding		2007 to June 2010		assets of German subsidiary
Euro Overdraft		Euro 0.7 million		4.2% - 5.3%		December		Common pool of assets
Facilities (Italy) (1)		($0.9 million)				2007		of Italian subsidiary
U.S. Demand Line (2)		80% of eligible		LIBOR plus 3.0%		June 2008		All assets held by our U.S.
		receivables, up to						parent company (IPG
		$7 million						Photonics Corporation)
Japanese Overdraft		JPY 600 million		2.13% - 2.25%		September		Pool of assets of
Facility (1)		($4.9 million)				2007		Japanese subsidiary
Chinese Overdraft		RMB 25 million		110% of RMB base rate		February		Unsecured
Facility		($3.3 million)				2008

     Operating activities. Cash used in operating activities in the six months ended June 30, 2007 was $2.0 million compared to $10.3 million provided by operating activities in the six months ended June 30, 2006. The increase in cash used in operating activities in the first six months of 2007 compared to the first six months of 2006 primarily resulted from:

•		A decrease in income taxes payable of $7.1 million in the first half of 2007 as compared to an increase in income taxes payable of $0.4 million in the same period last year. The decrease in income taxes payable in the first half of 2007 primarily resulted from estimated cash tax payments in Germany which increased by $12.7 million to $13.2 million in the first half of 2007 from $0.5 million for the first half of 2006. The cash taxes paid were offset by the current tax provision for each period; and
•		An increase in inventory of $11.7 million in the first six months of 2007 as compared to $6.4 million for the first six months of 2006 primarily related to an increase in work-in-process inventory of optical components and sub-assemblies and an increase in purchased components; partially offset by
•		An increase in net income.

     Given our vertical integration, rigorous and time-consuming testing procedures for both internally manufactured and externally purchased components and the lead time required to manufacture components used in our finished product, the rate at which we turn inventory has historically been low. We do not expect this to change significantly in the future and believe that we will maintain a relatively high level of inventory compared to our cost of sales. As a result we continue to expect to have a significant amount of working capital invested in inventory and for changes in our level of inventory to lead to an increase in cash generated from our operations when it is sold or a decrease in cash generated from our operations at times when the amount of inventory is increasing. A reduction in our level of net sales or the rate of growth of

our net sales from their current levels would mean that the rate which we are able to convert our inventory into accounts receivable would decrease.

     Investing activities. Cash used in investing activities was $17.8 million and $8.0 million in the six months ended June 30, 2007 and 2006, respectively. The cash used in investing activities in the first six months of 2007 was related to capital expenditures on plant and machinery and equipment primarily in the United States, Germany, China and Russia. The cash used in investing activities in 2006 was related to capital expenditures on plant and machinery and equipment of $9.1 million, primarily in the United States and Germany, which was partially offset by loan repayments of $1.1 million from the stockholders. Capital expenditures in the United States, Germany, China and Russia relate to our new diode wafer growth, fiber, new sales and service center and new production facilities, respectively. We expect to continue to invest in plant and machinery and to use a significant amount of our cash generated from operations to finance capital expenditures. The timing and extent of any capital expenditures in and between periods can have a significant effect on our cash flow. Many of the capital expenditure projects that we undertake have long lead times and are difficult to cancel or defer in the event that our net sales are reduced or if our rate of growth slows, with the result that it would be difficult to defer committed capital expenditures to a later period.

     Financing activities. Cash used by financing activities was $9.1 million in the six months ended June 30, 2007 compared to cash provided by financing activities of $0.4 million in the six months ended June 30, 2006. The cash used in financing activities in the first six months of 2007 was related to repayment of our long-term bank debt, partially offset by the net proceeds from the use of our credit lines. Cash provided by financing activities in the first six months of 2006 included $0.9 million of proceeds from the exercise of stock options, partially offset by repayments of long-term debt.

Cautionary Statement Regarding Forward-Looking Statements

     This Quarterly Report on Form 10-Q contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and we intend that such forward-looking statements be subject to the safe harbors created thereby. For this purpose, any statements contained in this Quarterly Report on Form 10-Q except for historical information are forward-looking statements. Without limiting the generality of the foregoing, words such as “may,” “will,” “expect,” “believe,” “anticipate,” “intend,” “could,” “estimate,” or “continue” or the negative or other variations thereof or comparable terminology are intended to identify forward-looking statements. In addition, any statements that refer to projections of our future financial performance, trends in our businesses, or other characterizations of future events or circumstances are forward-looking statements.

     The forward-looking statements included herein are based on current expectations of our management based on available information and involve a number of risks and uncertainties, all of which are difficult or impossible to accurately predict and many of which are beyond our control. As such, our actual results may differ significantly from those expressed in any forward-looking statements. Factors that may cause or contribute to such differences include, but are not limited to, those discussed in more detail in Item 1, “Business” and Item 1A, “Risk Factors” of Part I of our Annual Report on Form 10-K for the period ended December 31, 2006. Readers should carefully review these risks, as well as the additional risks described in other documents we file from time to time with the Securities and Exchange Commission. In light of the significant risks and uncertainties inherent in the forward-looking information included herein, the inclusion of such information should not be regarded as a representation by us or any other person that such results will be achieved, and readers are cautioned not to rely on such forward-looking information. We undertake no obligation to revise the forward-looking statements contained herein to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

Recent Accounting Pronouncements

     In July 2006, the FASB issued Financial Accounting Standards Interpretation No. 48, Accounting for Uncertainty in Income Taxes (“FIN 48”). FIN 48 prescribes a recognition threshold and measurement process for recording in the financial statements uncertain tax positions taken or expected to be taken in a tax return. FIN 48 also provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosures and transitions. FIN 48 became effective for us beginning January 1, 2007. We identified and reviewed potential uncertainties related to taxes upon the adoption of FIN 48. We determined that the exposure to those uncertainties did not have a material impact on our results of operations or financial condition.

     In September 2006, the FASB issued SFAS No. 157, Fair Value Measurements (“SFAS No. 157”), which addresses how companies should measure fair value when they are required to use a fair value measure for recognition or disclosure purposes under generally accepted accounting principles. The provisions of SFAS No. 157 are effective for us beginning after January 1, 2008. We have not yet adopted this pronouncement and we are currently evaluating the expected impact that the adoption of SFAS No. 157 will have on our consolidated financial position and results of operations.

     In February 2007, the FASB issued SFAS No. 159, The Fair Value Option for Financial Assets and Financial Liabilities (“SFAS No. 159”), which provides companies with an option to report selected financial assets and liabilities at fair value. SFAS No. 159 also establishes presentation and disclosure requirements relating to the use of fair values within the financial statements. The provisions of SFAS No. 159 are effective for us beginning after January 1, 2008. We have not yet adopted this pronouncement and are currently evaluating the expected impact that the adoption of SFAS No. 159 will have on our consolidated financial position and results of operations.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

     We are exposed to market risk in the ordinary course of business, which consists primarily of interest rate risk associated with our cash and cash equivalents and our debt and foreign exchange rate risk.

     Interest rate risk. Our investments have limited exposure to interest risk. To minimize this risk, we maintain a portfolio of cash, cash equivalents and short-term investments, consisting primarily of bank deposits, money market funds and short-term government funds. The interest rates are variable and fluctuate with current market conditions. Because of the short-term nature of these instruments, a sudden change in market interest rates would not be expected to have a material impact on our financial condition or results of operations.

     Our exposure to interest risk also relates to the increase or decrease in the amount of interest expense we must pay on our bank debt and borrowings on our bank credit facilities. The interest rate on our existing bank debt is currently fixed except for our U.S. demand line of credit. The rates on our Euro overdraft facilities in Germany and Italy and our Japanese Yen overdraft facility are fixed for twelve-month periods. Approximately 85% of our outstanding debt had a fixed rate of interest as of June 30, 2007. All of our U.S. and German term debt was repaid in the first quarter of 2007 except for the $20 million of subordinated notes issued to our series B stockholders upon completion of our IPO. We do not believe that a 10% change in market interest rates would have a material impact on our financial position or results of operations.

     Exchange rates. Due to our international operations, a significant portion of our net sales, cost of sales and operating expenses are denominated in currencies other than the U.S. dollar, principally the Euro and the Japanese Yen. As a result, our international operations give rise to transactional market risk associated with exchange rate movements of the U.S. dollar, the Euro and the Japanese Yen. Charges related to losses on foreign exchange transactions are reported as a component of general and administrative expense and totaled a $0.5 million gain and a $0.1 million loss in the six months ended June 30, 2007 and 2006, respectively.

     Historically, we have not utilized any derivative instruments or other measures to protect us against foreign currency exchange rate fluctuations. We will continue to analyze our exposure to currency exchange rate fluctuations and may engage in financial hedging techniques in the future to attempt to minimize the effect of these potential fluctuations. However, exchange rate fluctuations may adversely affect our financial results in the future.

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

     Under the supervision of our chief executive officer and our chief financial officer, our management has evaluated the effectiveness of the design and operation of our “disclosure controls and procedures” (as defined in Rules 13a-15(e) and 15d-15(e) promulgated under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), as of the end of the period covered by this Quarterly Report on Form 10-Q (the “Evaluation Date”). Based upon that evaluation, our chief executive officer and our chief financial officer have concluded that, as of the Evaluation Date, our disclosure controls and procedures are effective.

Changes in Internal Controls

     There was no change in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) promulgated under the Exchange Act) that occurred during the last fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

PART II—OTHER INFORMATION

Item 1. Legal Proceedings

     From time to time, we are party to various legal proceedings and other disputes incidental to our business. There have been no material developments in the second quarter of 2007 with respect to those proceedings previously reported in our Annual Report on Form 10-K for the year ended December 31, 2006.

Item 1A. Risk Factors

     In addition to the other information set forth in this report, you should carefully consider the factors discussed in Part I, “Item 1A. Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2006, which could materially affect our business, financial condition or future results and the risk factor below. The risks described in our Annual Report on Form 10-K and below are not the only risks facing our Company. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition and/or operating results.

     The markets for our products are highly competitive and increased competition could increase our costs, reduce our sales or cause us to lose market share.

     The industries in which we operate are characterized by significant price and technological competition. Our fiber laser and amplifier products compete with conventional laser technologies and amplifier products offered by several well-established companies, some of which

are larger and have substantially greater financial, managerial and technical resources, more extensive distribution and service networks, greater sales and marketing capacity, and larger installed customer bases than we do. Also, we compete with widely used non-laser production methods, such as resistance welding. We believe that competition will be particularly intense from makers of CO₂ and YAG lasers, as these makers of traditional laser solutions may lower prices to maintain current market share and have committed significant research and development resources to pursue opportunities related to these technologies.

     We also face competition from a growing number of fiber laser makers. We also expect competition from established laser makers that may have started or may start programs to develop and sell fiber lasers or solid state laser technology alternatives to fiber lasers Several established laser makers and others have recently introduced low and high-power fiber lasers, or have announced plans to develop fiber-based lasers, that would compete with our products. Because many of the components required to develop and produce low-power fiber lasers and amplifiers are commercially available, barriers to entry are relatively low, and we expect new competitive products to be introduced. We may not be able to successfully differentiate our current and any future products from our competitors’ products and current or prospective customers may not consider our products to be superior to competitors’ products. To maintain our competitive position, we believe that we will be required to continue a high level of investment in research and development, application development and customer service and support, and to react to pricing conditions. We may not have sufficient resources to continue to make these investments and we may not be able to make the technological advances or price adjustments necessary to maintain our competitive position. We also compete against our OEM customers’ internal production of competitive laser technologies.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

     None.

Item 3. Defaults Upon Senior Securities

     None.

Item 4. Submission of Matters to a Vote of Security Holders

     At the annual meeting of stockholders of IPG Photonics Corporation held on June 12, 2007, the stockholders considered and voted upon proposals to (i) re-elect the nine members of our board of directors to one-year terms and (ii) ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for 2007. Of the 39,987,570 shares present, the following number of shares voted for, against or withheld and abstained:

1.

Re-election of directors:

Nominee		Votes For				Votes Withheld
Valentin P. Gapontsev, Ph.D.			39,746,401				125,169
Eugene Shcherbakov, Ph.D.			39,736,732				134,838
Igor Samartsev			34,177,325				5,694,245
Robert A. Blair			39,611,068				260,502
Michael C. Child			39,814,777				56,793
John H. Dalton			39,732,887				138,683
Henry E. Gauthier			39,817,910				53,660
William S. Hurley			39,787,644				83,926
William F. Krupke, Ph.D.			39,790,277				81,293

2.

Ratification of the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for 2007:

Votes For		Votes Withheld		Abstentions
39,802,984		39,462		29,124

Item 5. Other Information

     None.

Item 6. Exhibits

     (a) Exhibits

Exhibit No.		Description
10.1		Loan Agreement dated as of July 26, 2007, between IPG Photonics Corporation and Bank of America, N.A.
10.2		Revolving Credit Note dated July 26, 2007 by IPG Photonics Corporation
31.1		Certification of Chief Executive Officer pursuant to Rule 13a-14(a)
31.2		Certification of Chief Financial Officer pursuant to Rule 13a-14(a)
32		Certification of Chief Executive Officer and Chief Financial Officer pursuant to Section 1350

SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned thereunto duly authorized.